Coming together to fight COVID-19: A conversation with Barry Greene, CEO of Sage Therapeutics

This year, our industry has been working around the clock to combat the COVID-19 virus, including developing effective therapeutics to treat COVID-19 and vaccines to prevent future infections. A key piece of that has been the impact the pandemic has had on mental health.

I had the opportunity to connect with Barry Greene, CEO of Sage Therapeutics, about the company’s efforts to address COVID-19’s impact.